1. Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study. (February 2023) Authors: Liu, Zhigang; Le, Kaixing; Zhou, Xin; Alexander, James L; Lin, Simeng; Bewshea, Claire; Chanchlani, Neil; Nice, Rachel; McDonald, Timothy J; Lamb, Christopher A; Sebastian, Shaji; Kok, Klaartje; Lees, Charlie W; Hart, Ailsa L; Pollok, Richard C; Boyton, Rosemary J; Altmann, Daniel M; Pollock, Kat... Journal: Lancet gastroenterology and hepatology Issue: Volume 8:Number 2(2023) Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P33 Patient/parent acceptability of different forms of oral hydrocortisone in congenital adrenal hyperplasia. Issue 5 (19th April 2023) Authors: Duncan, Jennifer; Bracken, Louise; Seddon, Gabrielle; Hill, Amy; Nuttall, Amy; Clarke, Ellie; Blundell, Pauline; Madine, Sarah; Gill, Andrea Journal: Archives of disease in childhood Issue: Volume 108:Issue 5(2023) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗